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In both developed and developing countries, 
breast cancer is still the most commonly diag-
nosed cancer among women, comprising 24.4% of 
all diagnosed malignancies among female cancer 
patients in Iran [1]. Various breast cancer man-
agement strategies exist based on the clinical and 
pathological characteristics of patients and tumors. 
Typically, a multidisciplinary approach is used, in 
which radiotherapy (RT) accounts for about 87% 
of breast cancers [2]. 
The technical advancement from 3D conformal 
radiotherapy (3D-CRT) to intensity-modulated 
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background: The role of the gastric volume on the dose-effect relationship for these organs has not been investigated. The 
aim of the study was to evaluate the correlation between gastric volume and dose-volume histogram (DVh) parameters of 
the heart, left lung and stomach during left breast cancer radiotherapy (rT). 
Materials and methods: Ninety-nine left breast cancer patients who got adjuvant radiotherapy were included. study was 
classified into two groups based on treatment field arrangements: 1) breast tangential fields only (T) and 2) breast tangential 
and supraclavicular fields (Ts). Organs DVhs were extracted. Descriptive statistics, pearson correlation, linear regression analy-
ses, and receiver operating characteristic (rOc) analyses were performed.
results: There is a direct but not significant correlation between the gastric volume and doses to the stomach and left lung. 
For a 100-cc increase in the gastric volume, the stomach maximum dose and the V50 increased by 3 Gy and 4%, respectively. 
For the left lung, V4 and V5 increased by 1% for Ts cases. considering rOc analysis results, one can make a decision for about 
74% of patients due to their left lung DVh parameters, using gastric volume as a known input data. The correlation between 
gastric volume and heart dose was not significant.
conclusions: The gastric volume of about 170 cc or less can result in lower dose to the stomach and ipsilateral lung during left 
breast cancer radiotherapy, especially for Ts cases. To reach this gastric volume threshold, patients should be fast for 2 hours 
before the procedure of cT simulation and treatment.
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radiotherapy (IMRT) and volumetric modulated 
arc therapy (VMAT) has occurred for almost all 
treatment sites over the past two decades. IMRT 
provided superior dose conformity, especially for 
concave target volumes, and optimal dose spar-
ing of adjacent normal tissues, but it might also 
increase the risk of radiation-induced secondary 
malignancies. Concerns about the secondary can-
cer of organs proximal to the fields, such as the 
contralateral breast, heart, and lung, have increased 
due to the higher low dose baths resulted from 
IMRT and VMAT [3]. Using the 3D-CRT tech-
nique, smaller volumes of normal tissues are poten-
tially exposed to lower radiation dose than IMRT. 
However, due to its shorter planning time, there are 
still many cancer institutes that prefer the 3D-CRT 
technique for breast cancer radiotherapy, especially 
in high-loaded centers [4]. Furthermore, IMRT 
is still an expensive treatment procedure. In Iran, 
about 10,000 new cases of breast cancer are diag-
nosed every year which leads to overloaded public 
radiotherapy centers [5]. For all of these reasons, 
3D-CRT is the first choice of breast cancer radio-
therapy in Iranian centers. Moreover, conventional 
fractionation by 2 Gy/day and total dose of 50 Gy, 
with/without boost dose to the tumor bed, has been 
prescribed as the standard of care [6].
Lungs, heart, and stomach are the considered 
organs at risk (OARs) in radiotherapy of the left 
breast. Exposure of these critical structures to ra-
diation may cause early and late sequelae. Because 
of increasing the general education level and stron-
ger prevention policies, it is hoped that cancers 
can be detected in early stages, so treatments can 
be started as soon as the diagnostic procedures are 
completed. Today, higher overall survival of breast 
cancer patients is expected. In this regard, late side 
effects of radio-therapeutic interventions and lim-
iting the risk of secondary cancer deserve more 
attention. 
Excess absolute risk (EAR) term has been de-
fined to represent the risk of developing a solid 
secondary cancer after radiotherapy. This concept 
can be estimated from the DVH of treatment plan-
ning [7]. Several risk models have been proposed 
to predict secondary cancer but still there is no ac-
curate prediction due to the lack of follow-up and 
epidemiological data [3]. 
The risk of secondary cancer for the ipsilateral 
lung was even estimated higher than for the other 
proximal organs; it receives a higher dose in or-
der to achieve a higher tumor control. Generally, 
known side effects of left breast RT included sec-
ondary lung malignancy, pneumonitis, lung fibro-
sis, cardiovascular diseases, and potential gastric 
complications [8–10]. The dose-effect relationship 
was directly proportional to: the higher the dose, 
the greater the complication rate. Studies indicate 
that pneumonitis (chronic or acute) and fibrosis 
have a direct correlation with radiation doses to the 
lung [11, 12]. 
Heart complication after radiotherapy of breast 
cancer has previously been studied. Two studies 
confirmed the probability of the coronary compli-
cations, including revascularization and myocardial 
infarction, increased linearly with the mean dose 
to the heart [13, 14]. The results of a cohort study 
proved that there was a significant dose-effect rela-
tionship between the probability of acute coronary 
events incidence and mean heart dose [15]. Cho 
et al. studied gastric complications after adjuvant 
radiotherapy for breast cancer. They concluded no 
chronic gastric complication was correlated with 
the radiation exposure during breast cancer irra-
diation [8]. Despite previous studies, the role of the 
gastric volume on the dose-effect relationship for 
the lung, heart, and stomach after the adjuvant left 
breast RT has not been investigated. 
Therefore, to minimize the amount of low dose 
volume such as the known V4 and V5 (Vx referred 
to the volume receiving more than x Gy), as well as 
the mean and maximum dose should be assessed 
for proximal OARs. This may reduce the risk of 
secondary cancer and other complications [3, 7]. 
This study aimed to evaluate the correlation 
between the gastric volume and the dose-volume 
histogram (DVH) parameters of the stomach, left 
lung, and heart during adjuvant radiotherapy for 
left breast cancer. This study also made an effort to 
propose a protocol for patients’ gastric preparation 
before the procedure of CT simulation and treat-
ment if any relationship between the DVH param-
eter and gastric volume was confirmed. 
Materials and methods
study population
Treatment planning data of 99 patients during 
two years from February 2018 to January 2020 
were studied, retrospectively. In this study partici-
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pants were patients treated by the 3D-CRT of the 
left breast cancer at Shohada-e Tarjish Hospital in 
Tehran, Iran. TNM and histological gradings were 
determined based on the National Comprehen-
sive Cancer Network (NCCN) guidelines [16]. The 
patients were referred for postoperative irradia-
tion based on their risk factors after mastectomy 
(MRM) or breast-conserving surgery (BCS) [17]. 
83 of the included cases were BCS and the other 
16 cases were MRM. The sampled population was 
classified into two groups according to the treat-
ment field arrangements: 1) tangential (T) fields 
and 2) tangential/supraclavicular (TS) fields. All 
patients were set up in the supine position dur-
ing CT simulations and radiotherapy treatments 
with the aid of a reproducible patient supporting 
system (AIO Breast®; Orfit; Belgium). For none 
of the considered cases electron beam was used 
and all were treated by the 6 MV photon beam of 
a CompactTM Linac (Elekta, Inc, Atlanta, USA). 
The treatment planning system was the ISOGray® 
Solution (DOSIsoft Ed. 4; France). The considered 
treatment phase in this study for BCS cases was 
justphase I (through which the whole breast was 
irradiated) without inclusion of any boost irradia-
tion. Posterior axillary field was used for all the 
selected TS cases.
contouring protocols
Sampled population involved patients with CT 
scan images covering the whole gastric volume. Left 
breast, chest wall, as well as auxiliary and supra-
clavicular lymph nodes were contoured based on 
the RTOG guideline [18]. Heart contour included 
the pulmonary artery and extended in the infe-
rior direction to the apex [19]. The gastric volume 
contoured began at the gastro-esophageal junction 
(GEJ) and ended at the pyloric canal opened to the 
duodenum. The cardia, fungus, body or corpus, 
antrum, and pylorus were included in the stomach 
structure [20, 21]. All delineated structures were re-
viewed by an expertise for consistency in contour-
ing. A sample of a left breast case with its delineated 
organs has been illustrated in Figure 1. 
Data collection
Treatment plans were evaluated in accordance 
with the national and international clinical pro-
tocols at the time of planning [22–26]. All of the 
dose constraints are according to QUANTEC. For 
example, for the lung: V20 < 30 %, for the heart: 
mean Gy, V25 < 10%. All of the included patients 
were treated by the conventional dose-fraction-
ation of 50 Gy in 25 fractions. The DVH param-
eters of the stomach, left lung, and heart were 
extracted from the approved treatment plans and 
used in the following statistical analyses. These 
parameters included the understudied organs Vx 
for different x Gy ranging from 4 Gy (as the low 
dose) to 50 Gy (as the prescription dose), their 
average/mean dose, and their maximum dose as 
presented in Table 1. 
statistical analysis
Descriptive statistics was used to describe in-
cluded patients and treatment characteristics. 
Pearson correlation and linear regression analysis 
were used to investigate the relationship between 
the DVH endpoints of OAR (stomach; left lung; 
heart) and the gastric volume using a statistical 
significance level of 0.05 (p-value < 0.05). Receiver 
operating characteristic (ROC) analysis was also 
used to validate the results calculated by the two 
statistical models. The area under the curve (AUC) 
metric evaluated the classification performance of 
the ROC model and assisted in determining the 
threshold of the gastric volume, when a strong cor-
relation with the DVH endpoint was confirmed 
Figure 1. a sample of left breast case with her delineated organs
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[27]. All of the statistical analyses were carried out 




Table 1 describes the statistics of the physical and 
dosimetric parameters of the three normal organs 
(stomach; left lung; heart) after the 3D-CRT of the 
left breast. The total sample size is 99: 51 cases were 
classified into the T group, and 48 cases into the TS 
group. Distribution of the patient’s age ranged from 
28 to 76, with the average age of 49 and standard 
deviation of 13. Categories of T1, T2, and T3 for 
staging of the primary tumor’s size accounted for 
46%, 19%, and 65%, respectively. Categories of N0, 
N1, N2, and N3 for staging of the spread to nearby 
lymph nodes accounted for 65%, 19%, 11%, and 
5%, respectively. Histologic grading of G1, G2, and 
G3 for classification of cancer cells’ growth and 
spread rates accounted for 21%, 65%, and 14%, 
respectively, of the total sample population. To be 
candidate for TS treatment patients had to have 
some indications; reported positive lymph nodes, 
categorized in T3 or T4 stages, not enough axillary 
lymph nodes were dissected or the result of senti-
nel biopsy was not convincing, and sometimes had 
medial lesions.
correlation tests
Table 2 summarizes the Pearson’s correlation and 
the linear regression results for potential correla-
tion between the gastric volume and the dosimetric 
parameters (shown in Tab. 1) for the stomach, left 
lung, and heart. Separate results were shown in the 
table for the T and TS cases in each statistical test. 
Figures 2–4 show the linear regression models for 
the relationships between the gastric volume and 
the V4 and V5 of the left lung, and DMax of the stom-
ach, respectively. For all of them the p-value was 
less than 0.05 and statistically significant, as shown 
in Table 2. Separate plots of the regression model 
were shown in these figures for the T and TS groups 
for each corresponding dosimetric parameter. 
Based on the obtained Pearson’s correlation co-
efficients (R) in Table 2, there are direct but very 
weak to moderate correlations between the gastric 
volume and the dose received by the stomach, heart 
and left lung for these cases. Non-zero and positive 
regression coefficients mean that by any increase 
in gastric volume, the related DVH of the stomach, 
left lung, and heart will increase. However, this re-
lationship was statistically significant just for V4 and 
V5 of left lung in TS cases (p-value < 0.05). 
Moreover, Figures 2–4 were plotted to make an 
easier illustration and discern the correlations be-
tween the DVHs parameters and gastric volume. 
These figures and their trendlines slope give an in-
table 1. Descriptive statistics for patients’ dose-volume histogram (DVh) parameters 
Organ Volume (cc) Volume (%) Dose [Gy]
Gastric
V45 V50 V55 DMax DMean
Min 69.00 0.00 0.00 0.00 0.00 0.64
Max 984.00 21.50 5.50 0.00 51.97 16.30
Mean 258.87 1.15 0.11 0.00 31.55 3.48
sD 180.95 3.27 0.68 0.00 18.65 3.13
Left 
lung
V4 V5 V8 V10 V11 V12.5 V16 V20 V30 DMean
Min 441.00 13.40 10.30 6.00 4.90 4.40 4.00 3.20 2.50 1.50 2.60
Max 1371.00 68.90 62.80 50.10 46.40 44.80 43.20 40.50 38.30 34.30 19.90
Mean 915.36 44.49 39.80 31.74 28.95 27.93 26.73 24.79 23.12 20.29 12.88
sD 183.76 13.16 12.27 10.28 9.56 9.30 9.00 8.53 8.10 7.45 4.03
heart
V8 V10 V16 V20 V25 V30 DMean
Min 250.00 3.05 2.67 2.06 1.74 1.53 1.23 1.60
Max 1046.00 50.60 35.30 32.70 31.60 30.10 28.74 11.20
Mean 539.65 15.63 14.71 12.81 12.07 11.97 10.72 8.58
sD 141.68 7.92 7.01 6.62 6.42 8.14 6.03 11.00
VX — the percent volume of organ receiving a dose of X Gy or more; DMax — maximum dose to the Oars; DMean — mean dose of Oars; Oar — organ at risk
Zahra Siavashpour al. correlation between gastric volume and organs at risk dose in adjuvant rT
371https://journals.viamedica.pl/rpor
y = –0.0036x + 34.641
R² = 0.0081
























y = –0.0035x + 30.807
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Figure 2. correlation between gastric volume and V4 of left lung
table 2. correlation between gastric volume and the stomach, left lung, and heart dose-volume histogram (DVh) 
parameters. T and Ts cases are considered separately
Organ Volume (%) Dose [Gy]
Gastric
V45 V50 DMax DMean
r T 0.31 0.49 0.31 0.27
Ts 0.12 0.03 0.27 0.09
r.c. T 0.01* 0.04 0.03** 0.00
Ts 0.00 0.00 0.03 0.00
p-value T 0.02 0.00 0.03 0.06
Ts 0.41 0.83 0.07 0.56
Left 
lung
V4 V5 V8 V10 V11 V12.5 V16 V20 V30 DMean
r T 0.09 0.09 0.10 0.11 0.11 0.11 0.12 0.11 0.11 0.12
Ts 0.33 0.31 0.22 0.22 0.21 0.20 0.18 0.16 0.14 0.17
r.c. T 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Ts 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00
p-value T 0.53 0.52 0.47 0.44 0.43 0.42 0.42 0.43 0.42 0.42
Ts 0.02 0.03 0.14 0.13 0.16 0.18 0.22 0.29 0.36 0.24
heart
V8 V10 V16 V20 V25 V30 DMean
r T 0.03 0.03 0.04 0.04 0.29 0.01 0.05
Ts 0.05 0.08 0.08 0.09 0.09 0.09 -0.08
r.c. T 0.00 0.00 0.00 0.00 0.01 0.00 0.00
Ts 0.00 0.00 0.00 0.00 0.00 0.00 0.01
p-value T 0.83 0.81 0.78 0.80 0.04 0.94 0.72
Ts 0.76 0.60 0.59 0.56 0.53 0.54 0.59
VX — the percent volume of organ receiving a dose of X Gy or more; DMax — maximum dose to the delineated Oar; DMean — radiation doses averaged across 
delineated Oar; T — cases treated with tangential fields; Ts — cases treated with tangential/supraclavicular fields; r — pearson’s correlation; rc — regression 
coefficient; *by every 1 cc increase in gastric volume its V45 will increase by 0.01% and so on for the other rc obtained for Oars’ VX; **by every 1 cc increase in 
gastric volume its DMax will increase by 0.03 Gy and so on for the other r.c. obtained for Oars’ DMax and DMean
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sight into the nature of the actual data, especially for 
the most significant results obtained from Table 2 
(i.e. V4, V5 of the lung and DMax of the stomach).
There is again a positive but weak to moderate 
association between maximum dose of the gastric 
volume and its volume for both T and TS groups. In 
each 100-cc increase in the gastric volume, its maxi-
mum dose would probably increase by 3 Gy, based 
on the obtained regression coefficients in Table 2.
There is no significant observed relationship be-
tween the gastric volume and heart dose during 
the left breast RT (Tab. 2). However, just for V25 of 
the heart in cases with tangential fields, there was 
a positive but not strong correlation with a report-
able R.C. that can be explained as before (i.e. by 
increasing 100 cc of gastric volume, V25 of the heart 
would probably increase by 1%).
rOc analysis
Using the descriptive analysis of DVH param-
eters (Mean ± SD) in addition to dose constraints 
suggested in the protocols mentioned earlier 
y = –0.0036x + 34.641
R² = 0.0081
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Figure 3. correlation between gastric volume and V5 of left lung
y = 0.0282x + 20.386
R² = 0.0927
























Figure 4. correlation between gastric volume and DMax of gastric
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(QUANTEC, EMAMI, RTOG 1005, and NSABP 
B-51), DVH thresholds were selected for the ROC 
analysis (Tab. 3 and Fig. 5–7).  
The ROC analyses between the gastric volume 
and its V45, V50, and V55 parameters resulted in no 
predictive ability of gastric volume for these DVH 
parameters. However, the resulted AUCs of analy-
sis between gastric volume and its maximum dose 
were 0.77 (sensitivity = 0.80 and specificity = 0.61) 
and 0.65 (sensitivity = 0.61 and specificity = 0.64) 
for T and TS groups, respectively (Fig.  5). The 
cut-off point of gastric volume for T cases was 
about 230 cc and for TS cases was about 185 cc. 
These results were obtained after classification of 
DMax into two binary groups of 0: DMax ≤ 45 Gy and 
1: DMax > 45 Gy, the tested state was 1. This analysis 
was also repeated for average dose of the stomach. 
For T cases no meaningful results were obtained af-
ter binary classification of the dose (0: DMean ≤ 10 Gy 
and 1: DMean > 10 Gy). For the TS group and with the 
gastric volume cut-off point of about 220 cc, AUC 
was 0.59 with sensitivity and specificity of 0.67 and 
0.69, respectively. Other reportable ROC curves for 
the left lung and heart DVH parameters are illus-
trated in Figures 6 and 7 and the analyses detailed 
results are presented in Table 3.
Discussion
In different radiotherapy departments, based on 
their available image guidance facilities, such as 
electronic portal imaging device (EPID), cone-beam 
CT (CBCT) or even using MR-linac, several univer-
sal and/or local protocols are followed for patients’ 
pre-simulation and pre-treatment preparation to 
reduce the radiation dose received by OARs and 
improve the adaptive treatment reproducibility [28]. 
However, there is no written preparation protocol 
for breast cancer irradiation regarding the gastric 
volume and, because of that, the high standard de-
viation of 181 cc (ranged from about 69 cc to 984 
cc) for the gastric volume was achieved in Table 1. 
In adjuvant RT of left-sided breast cancer, treat-
ing regional lymph node led to a remarkable in-
crease in heart and lung doses [29]. Based on the 
recent systematic review by Anzar et al. MLDipsi in 
table 3. receiver operating characteristic (rOc) curve characteristics for dose-volume histogram (DVh) parameters
Organ Volume (%) Dose [Gy]
Left lung
V4 V5 V8 V10 V11 V12.5 V16 V20 V30 DMean
DVh threshold > 50 > 50 > 35 > 35 > 35 > 30 > 25 > 25 > 20 > 15
aUc T N N 0.35 0.61 N 0.37 0.38 0.42 0.44 0.45
Ts 0.77 0.67 0.85 0.62 0.68 0.80 0.79 0.78 0.70 0.79
sensitivity T N N 0.50 1.00 N 0.67 0.64 0.75 0.67 0.68
Ts 0.68 0.68 0.74 0.7 0.68 0.68 0.68 0.76 0.65 0.68
specificity T N N 0.57 0.59 N 0.38 0.37 0.39 0.39 0.49
Ts 0.67 0.54 0.67 0.61 0.59 0.86 0.75 0.57 0.80 0.75
cutoff (cc) T N N 290 288 N 172 172 172 172 228
Ts 163 173 154 177 170 168 162 146 168 162
heart
V8 V10 V16 V20 V25 V30 DMean
DVh threshold > 25 > 25 > 20 > 15 > 10 > 10 > 4
aUc T 0.30 0.14 0.48 0.44 0.59 0.53 0.59
Ts 0.54 0.53 0.56 0.56 0.50 0.48 0.54
sensitivity T 0.67 1.00 0.80 0.64 0.77 0.75 0.76
Ts 0.71 0.67 0.64 0.71 0.55 0.57 0.50
specificity T 0.29 0.14 0.31 0.38 0.49 0.45 0.44
Ts 0.54 0.52 0.54 0.33 0.58 0.45 0.82
cutoff (cc) T 150 117 150 172 172 172 148
Ts 182 182 182 154 182 172 275
VX: — the percent volume of organ receiving a dose of X Gy or more; DMean — mean dose of Oars; aUc — area under the curve;  T — cases treated with tangential 
fields; Ts — cases treated with tangential/supraclavicular fields; N — non reportable due to the low sample size
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Figure 5. rOc analysis results of gastric volume predictability for its maximum dose. DMax was classified into two binary 
groups; 0: Gastric DMax ≤ 45 Gy and 1: Gastric DMax > 45 Gy and the tested state was 1. Left picture is for T (cases treated with 
tangential fields), and the right one for Ts (cases treated with tangential/supraclavicular fields) groups
V5 L > 50% V8 L > 35% V10 L > 35% 
V11 L > 35% V12.5 L > 30% V16 L > 25% 
Figure 6. rOc analysis results of gastric volume predictability for left lung DVh parameters (L — left lung). T — cases treated 
with tangential fields; Ts — cases treated with tangential/supraclavicular fields
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breast radiotherapy with no breathing adaption in 
a supine position, it was 8.4 Gy for whole breast 
or/and chest-wall RT and 11.2 Gy when the axilla 
or/and supraclavicular fossa was irradiated [12]. 
That’s why considered cases were classified into two 
groups of T and TS in the current study.
The mean ± SD of the left lung dose obtained 
12.9 ± 4.0 Gy which was close to the data reported by 
Anzar MC et al.  from their meta-analysis of confor-
mal radiotherapy with tangent fields (10.9 ± 0.8 Gy) 
and IMRT (11.7 ± 1.1 Gy) [12]. Referring to the DMean 
definition, any fluctuation in the lung volume can 
influence the resultant mean dose. Mean ± SD of the 
left lung volume was 915.4 ± 183.8 cc for the cases 
being studied. Not following any breathing protocols 
during simulation can add more lung volume varia-
tions beside the intrinsic variation between different 
patients’ anatomies. Therefore, high standard devia-
tion could be due to the absence of any breathing 
protocols during patients’ CT simulation.
Considering the recent publication by Cho WK 
et al., a five-year follow-up of breast cancer patients 
indicated that adjuvant RT is not a risk factor in late 
gastric cancer [8]. Despite the fact that the stomach 
is considered as a radioresistant organ (maximum 
tissue tolerance dose with 5% rate of gastric compli-
cation in 5 years (TD 5/5) is 50 Gy based on Emami 
B. et al.), gastric ulceration risk would be 16% if it 
receives more than 50 Gy dose as reported by Brick 
IB et al. [26, 30]. For T cases, the regression coef-
ficient (R.C.) was 0.04 (Tab. 2), which means that 
by increasing gastric volume in every 100 cc its 
V50 may increase by 4%. Therefore, fuller stomach 
increases the risk of gastric ulceration during left 
breast irradiation.
Based on Table 2, dependency of the ipsilateral 
lung volume that would receive low dose on the 
gastric volume is higher for TS cases than T ones. 
The apex of lung is irradiated to a higher dose by 
the tangential/supraclavicular RT fields and a high-
er correlation coefficient for TS was obtained com-
pared to the T group referring to their Pearson 
coefficients (e.g. 0.09 for T vs. 0.33 for the TS cases’ 
V4). Using this direct correlation, the dose given 
to the lung can be managed better by controlling 
the gastric volume. For example, by considering 
regression coefficients of TS cases, one can con-
clude that an increase of 100 cc in gastric volume 
Figure 7. receiver operating characteristic (rOc) analysis results of gastric volume predictability for heart dose-volume 
histogram (DVh) parameters. h — heart; T — cases treated with tangential fields; Ts — cases treated with tangential/ 
/supraclavicular fields
V8 H > 25% V16 H > 20% V20 H > 15% 
V25 H > 10% V30 H > 10 DMean H > 4 Gy 
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may significantly raise V4 and V5 of the left lung by 
1 percent (100 cc × 0.01 = 1) with p-value of 0.02 
and 0.03, respectively. As mentioned, this correla-
tion is much stronger in treatment of lymph node 
positive cases (TS) than the negative ones (T). The 
other DVH parameters of the left lung had a direct 
but moderate relationship with the gastric volume 
by approximately the same regression coefficients. 
However, the obtained associations were not strong 
(based on the calculated Pearson correlation coef-
ficients) and not significant (based on the P-values) 
for this study population. Based on previous stud-
ies, such as Zhao H et al. and Drachman CB et al. 
review articles, radiation-induced secondary can-
cer is a concern that needs attention, especially in 
the irradiated organ volumes where the received 
dose from the primary fields exceeds 2.5 Gy [31, 
32]. Furthermore, due to an individual patient data 
meta-analysis of 75 randomized trials, every 1 Gy 
increase in the mean dose of the lung during the ra-
diotherapy of breast cancer, the risk of lung cancer 
increases by 11% after a decade from radiotherapy 
[12, 33]. However, there is no significant correlation 
(p-value > 0.05) between the mean dose of the left 
lung and the gastric volume in the current study. 
This randomized trial was performed by Taylor et 
al. and they also reported that the average of ipsi-
lateral lung dose in modern breast radiotherapy 
was 9.0 Gy and the average of whole-lung dose was 
about 5.0 Gy. They also calculated the excess rate ra-
tio (ERR) per Gy of whole-lung dose for incidence 
of lung cancer for two smoking and non-smoking 
groups. Based on their obtained ERR, the risk of 
mortality from radiation induced lung cancer is 
much higher in the smoking (from 9.4% to 13.8%) 
than nonsmoking group (from 0.5% to 0.8%). If the 
whole lung dose becomes higher, the excess risk 
will also be higher [33].
Based on previous studies, even a small heart 
dose can lead to cardiac disease as shown by the 
relative increase in this complication per gray [13]. 
There is a negative correlation [but weak and not 
significant (p-value > 0.05)] between the mean dose 
of the heart and the gastric volume for the current 
TS cases (by R.C. ≈ –0.01; by every increase of 
100 cc in the gastric volume the heart mean dose 
may decrease by 1 Gy). Darby et al. reported the 
linear correlation coefficient between the rate of 
acute coronary events and heart mean dose (7.4% 
per 1 Gy) after radiotherapy of the left breast [14]. 
Van Den Bogaard et al. studied the relationship 
between acute coronary disease and the mean dose 
of the heart and indicated that its cumulative in-
cidence increased by 16.5% per 1 Gy mean heart 
dose 9 years after this treatment [15]. Beaton et al. 
also assessed the cardiovascular disease (CVD) of 
women after 10 years of their left breast RT and 
checked if QUANTEC guidelines violation had any 
relationship with dying from this disease [9]. They 
concluded that the risk of death from CVD after 10 
years of left breast RT is very low if the heart mean 
dose had been kept less than 3.3 Gy. However, weak 
correlation was detected between the heart dose 
and gastric volume in the current study. 
AUC was approximately 0.77 for ROC analysis 
between the gastric volume and its maximum dose, 
which means that the gastric volume can classify 
about 77% of patients and specify whether their 
Dmax of the stomach is more than 45 Gy or not (Fig. 
5). Also, the sensitivity and specificity of 0.80 and 
0.61 show that by possessing 185 cc as a cut-off 
point for gastric volume, the Dmax of the stomach in 
80% of patients can be predicted to be more than 45 
Gy and in 61% of them to be less than 45 Gy. 
The column V4 of the left lung for TS cases in 
Table 3 can be interpreted based on the estimated 
indices. For this column, the AUC of 0.77 tells us 
that by considering the gastric volume one can truly 
classify about 77% of patients based on whether 
their left lung V4 is more than 50% or not. The ob-
tained sensitivity of 0.68 for TS cases with gastric 
volume cut-off of about 163 cc indicates that us-
ing this cut-off point, one can truly predict about 
68% of patients’ left lung V4 parameters to be more 
than 50%. One the other hand, its specificity of 
0.67 also indicates that by using this cut-off point 
it is predictable for about 67% of patients’ V4 of the 
stomach  to be less than 50%. 
Similar to V4, using AUCs calculated for the oth-
er left lung DVH parameters of TS cases (Tab. 3), by 
knowing the gastric volume one can truly classify 
about 67%, 85%, 62%, 68%, 80%, 79%, 78%, 70%, 
and 79% of patients based on whether their left lung 
V5, V8, V10, V11, V12.5, V16, V20, V30, and DMean is more 
than 50%, 35%, 35%, 35%, 30%, 25%, 25%, 20%, 
and 15 Gy or not, respectively. Eventually, by using 
gastric volume data one may probably make a good 
prediction for about 75% (i.e. the average of all left 
lung DVH parameters’ AUC) of these patients’ left 
lung DVH parameters. 
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AUCs of T cases were almost less than 0.50, 
which means that by considering the gastric vol-
ume as a known data, DVH parameters of the 
ipsilateral lung can be foreseen for less than 50% 
of patients. However, just for V10 of the left lung 
in T cases, AUC obtained was 0.61, which means 
that by managing the gastric volume (with a cut-off 
point of about 288 cc) just for 61% of patients, one 
can truly predict whether left lung V10 is more than 
35% or not.
AUC resulted from ROC analysis of TS cases, 
the V8, V10, V16, and V20 parameters of the heart 
with thresholds of 25%, 25%, 20%, and 15% were 
about 0.54, 0.53, 0.56, and 0.56, respectively. For 
example, the column V10 of the heart with 25 Gy 
threshold can be explained so that just 53% of 
patients can be truly classified based on whether 
their heart V10 is less than 25 Gy or not. The sen-
sitivity of 0.67 with 182 cc cut-off point for the 
gastric volume shows that for 67% of patients, V10 
of the heart can be predicted to be less than 25 %. 
Nevertheless, the specificity of 0.52 shows that by 
using this cut-off point for 52% of patients, V10 of 
the heart can be predicted to be more than 25%, 
which is not reliable predictor data. Therefore, 
gastric volume is not a good predictor of the heart 
dose neither for TS nor for T cases. However, 
as a suggestion for future study, the heart’s left 
descending artery (LAD) and left ventricle (LV) 
could also be delineated and assessed by having 
patients’ CT scans acquired with a contrast agent 
to see if there is any correlation between their dose 
and gastric volume. 
The average of all gastric volume cut-off points 
for  the studied DVH parameters of the left lung 
and heart were 161 ± 12 cc and 176 ± 11 cc, re-
spectively. Therefore, it can be concluded that the 
gastric volume of about 170 cc can result in an 
optimal situation for the stomach, left lung, and 
heart dose reduction during left breast cancer ra-
diotherapy, especially with tangential plus supra-
clavicular fields. Based on the Hunt et al. study, 2 
hours fasting can lead to an empty stomach [34]. 
There are also some previous studies that followed 
2 hours fasting to reach a semi-empty stomach for 
radiotherapy purpose [35]. Therefore, considering 
about 2 hours fasting before CT simulation and 
every radiotherapy fraction can help patients reach 
this gastric volume and subsequent OARs’ dose. 
In addition, by this gastric volume the control of 
the risk of secondary cancer for the left lung would 
probably decrease, especially for TS cases, due to 
the reduction of its low dose.
Low statistical population can be named as the 
most limitation of current cross-sectional study. 
The non-uniformity of some ROC curves in Figures 
5–7 with non-rounded shape was apparently due to 
the inadequate sample size in its related subgroup. 
The authors suggest a future prospective study on 
the DVH parameters of each mentioned OARs and 
follow up the related radiotherapy sequelae. Pa-
tients can be classified based not only on their T or 
TS prescribed treatment status but also based on 
their body surface area (BSA) which could lead to 
some bias to the current study results.
Eventually, to be able to suggest some recom-
mendations as a patient preparation protocol for 
left breast cancer adjuvant radiotherapy, more mul-
ticentric randomized trial and meta-analysis stud-
ies are required. Image guided radiotherapy with 
cone beam CT or even MRI can give more reliable 
data about the exact position of soft tissues, like the 
stomach, during radiotherapy and its impact on the 
anatomical shift of its surrounding organs. 
conclusions
In this retrospective study, the effect of gastric 
volume on dose received by the stomach, heart, 
and left lung was evaluated during adjuvant ra-
diotherapy of left breast cancer patients. Due to 
the obtained correlations, decreasing the gastric 
volume would reduce the ipsilateral lung mean 
dose. It also decreases the volumes that reach the 
low dose during left breast irradiation. This dose 
reduction may reduce the risk of patients’ second-
ary lung cancer during the following decades of 
RT. The correlations between the gastric volume 
and heart DVH parameters was found non-sig-
nificant. Maximum dose to the stomach is associ-
ated with its volume during RT. Any non-invasive 
interference that could reduce these OARs’ dose 
would be appreciated during left breast radio-
therapy. 
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